220 related articles for article (PubMed ID: 16634806)
1. Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer.
Lin T; Liang S; Meng F; Han Q; Guo C; Sun L; Chen Y; Liu Z; Yu Z; Xie H; Ding J; Fan D
Clin Exp Immunol; 2006 May; 144(2):319-25. PubMed ID: 16634806
[TBL] [Abstract][Full Text] [Related]
2. Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier.
Guo CC; Ding J; Pan BR; Yu ZC; Han QL; Meng FP; Liu N; Fan DM
World J Gastroenterol; 2003 Jun; 9(6):1191-5. PubMed ID: 12800222
[TBL] [Abstract][Full Text] [Related]
3. Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer.
Meng FP; Ding J; Yu ZC; Han QL; Guo CC; Liu N; Fan DM
World J Gastroenterol; 2005 Mar; 11(12):1833-6. PubMed ID: 15793876
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immune response to gastric cancer specific antigen Peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsion.
Shi R; Hong L; Wu D; Ning X; Chen Y; Lin T; Fan D; Wu K
Cancer Biol Ther; 2005 Feb; 4(2):218-24. PubMed ID: 15753659
[TBL] [Abstract][Full Text] [Related]
5. Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus.
Pan Y; Jia R; Li J; Wang M; Chen S; Liu M; Zhu D; Zhao X; Wu Y; Yang Q; Yin Z; Jing B; Huang J; Zhang S; Zhang L; Liu Y; Yu Y; Tian B; Pan L; Rehman MU; Cheng A
Virol J; 2020 May; 17(1):67. PubMed ID: 32398028
[TBL] [Abstract][Full Text] [Related]
6. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
[TBL] [Abstract][Full Text] [Related]
7. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice.
Chunling M; Kun Y; Jian X; Jian Q; Hua S; Minsheng Z
Intervirology; 2006; 49(5):307-18. PubMed ID: 16809936
[TBL] [Abstract][Full Text] [Related]
8. Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.
Näslund TI; Uyttenhove C; Nordström EK; Colau D; Warnier G; Jondal M; Van den Eynde BJ; Liljeström P
J Immunol; 2007 Jun; 178(11):6761-9. PubMed ID: 17513723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of protective efficacy induced by different heterologous prime-boost strategies encoding triosephosphate isomerase against Schistosoma japonicum in mice.
Dai Y; Zhao S; Tang J; Xing Y; Qu G; Dai J; Jin X; Wang X
Parasit Vectors; 2017 Feb; 10(1):111. PubMed ID: 28241779
[TBL] [Abstract][Full Text] [Related]
10. [Development of oral DNA vaccine based on MG(7)-Ag mimotope of gastric cancer].
Guo C; Ding J; Yu Z; Han Q; Meng F; Liu N; Fan D
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):110-3. PubMed ID: 12015027
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen.
Haq K; Jia Y; Elahi SM; MacLean S; Akache B; Gurnani K; Chattopadhyay A; Nazemi-Moghaddam N; Gilbert R; McCluskie MJ; Weeratna RD
Vaccine; 2019 Nov; 37(47):7029-7040. PubMed ID: 31506193
[TBL] [Abstract][Full Text] [Related]
12. Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.
Dai MS; Vassaux G; Xu M; You RI; Hsieh YF; Ouisse LH; Lo KY; Sytwu HK; Chao TY
Vaccine; 2012 Nov; 30(48):6903-11. PubMed ID: 22982404
[TBL] [Abstract][Full Text] [Related]
13. MG7 mimotope-based DNA vaccination for gastric cancer.
Zhang D; Chen Y; Fan D
Expert Rev Vaccines; 2006 Apr; 5(2):223-31. PubMed ID: 16608422
[TBL] [Abstract][Full Text] [Related]
14. Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy.
Kongkasuriyachai D; Bartels-Andrews L; Stowers A; Collins WE; Sullivan J; Sattabongkot J; Torii M; Tsuboi T; Kumar N
Vaccine; 2004 Aug; 22(23-24):3205-13. PubMed ID: 15297075
[TBL] [Abstract][Full Text] [Related]
15. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
16. Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice.
Yu M; Qiu Y; Chen J; Jiang W
Virus Genes; 2016 Apr; 52(2):228-34. PubMed ID: 26837895
[TBL] [Abstract][Full Text] [Related]
17. A novel DNA vaccine containing four mimicry epitopes for gastric cancer.
Chen Y; Wu K; Guo C; Liu C; Han S; Lin T; Ning X; Shi R; Shi Y; Fan D
Cancer Biol Ther; 2005 Mar; 4(3):308-12. PubMed ID: 15876863
[TBL] [Abstract][Full Text] [Related]
18. Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.
Ratto-Kim S; Currier JR; Cox JH; Excler JL; Valencia-Micolta A; Thelian D; Lo V; Sayeed E; Polonis VR; Earl PL; Moss B; Robb ML; Michael NL; Kim JH; Marovich MA
PLoS One; 2012; 7(9):e45840. PubMed ID: 23049876
[TBL] [Abstract][Full Text] [Related]
19. Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs.
Fukumoto S; Tamaki Y; Okamura M; Bannai H; Yokoyama N; Suzuki T; Igarashi I; Suzuki H; Xuan X
Vaccine; 2007 Jan; 25(7):1334-41. PubMed ID: 17055131
[TBL] [Abstract][Full Text] [Related]
20. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
